How to read the results of the first-ever medical-breast augmentation surgery in the U.S.
The U.K.’s Buckingham Heart surgery is the first in the world to use the new technology to remove and reconstruct the large, damaged, and delicate heart.
The surgeons at Royal Liverpool and Liverpool Children’s Hospital successfully removed more than 70% of the heart, using a new technique called a “bronchorionic implant.”
The surgery will allow doctors to restore the patient’s heart function.
The British Heart Foundation has partnered with the Royal Liverpool Hospital to provide the funding for the surgery.
“We have been in the business of treating patients since the dawn of medicine, and this is a very important first step,” says Dr. Rufus Jones, chairman of the Royal London Hospital.
“It will mean we can get more patients into the operating room, and the patients will get better outcomes.”
A study from the Royal Free Hospital in London revealed the surgeons had a 99% success rate with a single surgery.
surgery will likely be the first to be used on patients with severe heart disease, where there is limited or no ability to safely perform heart surgery.
That makes the British hospital’s procedure more accessible to patients in the developing world and to the middle class who are less likely to have insurance.
“I think this is the only country in the developed world where this has been performed,” says Jules Cauchon, a cardiologist and surgeon at the Royal Hospital of Great Britain.
“And this is something that we’re really excited about.”
Dr. Jones and the Royal Children’s Research Institute have been working to improve the technology.
“This is the most exciting thing we’ve ever done, because we are the first hospital in the country to actually do it,” he says.
We’re not expecting to be perfect, but it’s a very promising device.” “
We’re not going to say that the device is perfect, because this is really just a trial.
We’re not expecting to be perfect, but it’s a very promising device.”
The first-in-the-world surgery at the British Heart Hospital was performed on April 20, 2018, and is the result of a two-year, $50 million trial that has already led to the first successful results in patients with mild or moderate heart disease.
“The technology is here to stay,” says Jones.
“There’s still a lot of work to be done.
But we think that the technology is very promising and it has been validated in the very, very few patients.”
“I would like to thank the British government for their support in this amazing initiative, and I would also like to extend my gratitude to the British people for their unwavering support,” says Cauchard.